News from Veracyte A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 19, 2017, 08:03 ET Awareness Campaign Takes Lung Cancer Risk Head-On, Asking North Carolinians To Screen Together

Veracyte, Inc. today announced the launch of Screen Together (www.ScreenTogether.com), an awareness campaign aimed at increasing routine screening...


Jun 27, 2017, 08:05 ET Veracyte Announces Publication of Study Supporting the Development of Envisia™ Genomic Classifier for IPF in Annals of the American Thoracic Society

Veracyte, Inc. (NASDAQ: VCYT) announced today that results of a study supporting the early development of the Envisia Genomic Classifier have been...


Jun 26, 2017, 08:00 ET Veracyte Named a San Francisco Bay Area "Top Workplace" For Fourth Consecutive Year

Veracyte, Inc. (NASDAQ: VCYT) announced today that it has been awarded a 2017 Top Workplaces honor by the Bay Area News Group. This marks the...


Jun 01, 2017, 13:00 ET Veracyte to Present at William Blair 2017 Growth Stock Conference

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the William Blair 2017...


May 23, 2017, 15:00 ET Veracyte Announces Clinical Validation Data Demonstrating Envisia™ Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


May 18, 2017, 12:58 ET Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving...


May 11, 2017, 08:30 ET Data Demonstrating Cost-Effectiveness of Veracyte's Percepta® Bronchial Genomic Classifier Published in "Journal of Thoracic Oncology"

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


May 10, 2017, 08:00 ET Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


May 08, 2017, 08:00 ET Data Presented at AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte's Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


May 04, 2017, 16:05 ET Veracyte Announces Pivotal Clinical Validation Data for Next-Generation Afirma® Test To Help More Patients Avoid Unnecessary Surgery in Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


May 03, 2017, 16:05 ET Veracyte Announces First Quarter 2017 Financial Results

Revenue was $16.4 Million, a 21% Growth Over Prior Year Cash Burn was $8.3 Million, a 28% Improvement Over Prior Year Conference Call and...


Apr 26, 2017, 08:00 ET Veracyte Announces Multiple Studies Demonstrating Powerful Results from Afirma® Classifiers To Be Presented at the AACE 2017 Annual Meeting

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Apr 19, 2017, 16:30 ET Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017

Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its first quarter 2017 financial results after close of market on Wednesday, May...


Apr 03, 2017, 12:00 ET Multiple Studies Presented at ENDO 2017 Support Use of Veracyte's Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Mar 23, 2017, 08:00 ET Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Mar 01, 2017, 16:05 ET Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook

Revenue Grew 31%, to $65.1 Million in 2016 Full-Year Afirma® GEC Volume Increased 20%, to 23,237 Tests Conference Call and Webcast Today at...


Feb 28, 2017, 16:05 ET Veracyte Announces Executive Promotions

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 27, 2017, 10:20 ET Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 21, 2017, 08:00 ET Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 15, 2017, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017

Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its fourth quarter and full-year 2016 financial results after close of market on...


Feb 08, 2017, 08:00 ET Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 06, 2017, 08:00 ET Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 02, 2017, 08:00 ET Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman of the board, president and chief executive officer, will present...


Dec 13, 2016, 08:00 ET Veracyte Announces Appointment of Kevin K. Gordon and Other Changes to Its Board of Directors

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


Nov 22, 2016, 07:00 ET Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma® Gene Expression Classifier in 2017

Veracyte, Inc. (NASDAQ: VCYT) announced today that the Centers for Medicare and Medicaid Services (CMS) has released its revised final 2017...